GMED Globus Medical Inc Class A

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 4:30 pm Pacific Time

AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT.

Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” section of the Globus Medical investor relations website at .  

About Globus Medical, Inc. 

Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, regenerative biomaterials and enabling technologies. Additional information can be accessed at .  

Investor contact: 

Brian Kearns 

610-930-1800 

 

Media contact: 

Moran Chavez 

 



EN
06/03/2025

Underlying

GMEDGlobus Medical Inc Class A

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Globus Medical Inc Class A

 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical to participate in the Canaccord Genuity 2025 Musculoske...

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference Monday, March 10, 2025 at 4:30 pm Pacific Time AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT. Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” section of...

21h / 23m 1 EN
Free Trial
GMED Globus Medical ...

Globus Medical Inc: 1 director

A director at Globus Medical Inc sold 7,500 shares at 78.680USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

GMED GLOBUS MEDICAL INC CLASS A
03/05/25 March 5, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Globus Medical Reports Fourth Quarter and Full Year 2024 Results AUDUBON, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024: Worldwide net sales were $657.3 million, an increase of 6.6% on an as-reported basis and an increase of 6.9% on a constant currency basisGAAP net income for the quarter was $26.5 millionGAAP diluted earnings per share (“EPS”) was $0.19 and non-GAAP diluted EPS was $0.84Non-GAAP ...

February 20, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for ...

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced they have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an all-cash transaction. Under the terms of the agreement, which was unanimously approved by the bo...

February 6, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Re...

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2024 after the market close on Thursday, February 20, 2025. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Part...

January 30, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch